Provider
P3-18 New Drug-Related PA Criteria: Inhaled Antibiotics Duplicate Therapy
Program effective Date: Jan 24, 2018
Documents & Forms Results
Displaying 2841 - 2850 of 3102 results
Provider
P4-18 Changes to Medical Policy IV-126 Sacroiliac Joint Fusion
Program effective Date: Jan 24, 2018
Provider
QP7-18 Disclosure of Ownership Form
Program effective Date: Jan 18, 2018
Provider
QP6-18 Updated Commercial PA Request Form and PA List for Early Intensive Behavioral Intervention Services
Program effective Date: Jan 17, 2018
Provider
QP5-18 Quality Initiatives at Blue Cross
Program effective Date: Jan 16, 2018
Provider
QP4-18 Remember to Request Subscriber ID Cards
Program effective Date: Jan 16, 2018
Provider
P2-18 New Medical Drug PA Requirements for Voretigene Neparvovec (Luxturna)
Program effective Date: Jan 11, 2018
Provider
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Program effective Date: Jan 09, 2018
Provider
QP3-18 Pharmacy Benefit Update - Helixate FS Will No Longer Be Covered
Program effective Date: Jan 08, 2018
Provider
QP2-18 Pharmacy Benefit Exclusion for Luxturna
Program effective Date: Jan 08, 2018